From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.

Bristol Myers Squibb gets European Commission approval to expand use of CAR T cell therapy, Breyanzi for relapsed or refractory follicular lymphoma: Princeton, New Jersey Monday, ...

Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation ("Geron" or the "Company") and certain officers. The class action, filed in the United States District ...

Jonathon Whitton, AuD, PhD, VP, auditory global program head, Regeneron, discusses how the focus of technology development is shifting toward ensuring safety and continuous hearing for children.

Discover why some women develop fibroids while others don't, from genetics and hormones to lifestyle and environmental ...

Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that members of management ...

Researchers successfully pulled off the first eye stem cell transplants to help heal cornea damage, and the results speak for ...

A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...

Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he ...